Strategic Plan Question Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Question 4: Which Treatments And Interventions Will Help? (Treatments)  

$68,123,890.33
Fiscal Year: 2010

Download 2010 Question 4 projects (EXCEL)
Note: Initial Sort is by Principal Investigator. Sorting by other columns is available by clicking on the desired column header.
Project Title Principal Investigator Strategic Plan Objective Institution
Characterization of the transcriptome in an emerging model for social behavior Thomas, James Q4.S.B Emory University
Genomic resources for identifying genes regulating social behavior Young, Larry Q4.S.B Emory University
Vasopressin receptors and social attachment Young, Larry Q4.S.B Emory University
Neural mechanisms of social cognition and bonding Young, Larry Q4.S.B Emory University
Neural mechanisms of social cognition and bonding Young, Larry Q4.S.B Emory University
Central vasopressin receptors and affiliation Young, Larry Q4.S.B Emory University
Central vasopressin receptors and affiliation Young, Larry Q4.S.B Emory University
1/2-Effects of parent-implemented intervention for toddlers with autism spectrum disorder Wetherby, Amy Q4.S.D Florida State University
A randomized trial of the SCERTS curriculum for students with autism spectrum disorders in early elementary school classrooms Wetherby, Amy Q4.S.D Florida State University
Effects of parent-implemented intervention for toddlers with autism spectrum disorders Wetherby, Amy; Lord, Catherine Q4.L.D Florida State University; University of Michigan
Handheld technology to assist students with autism spectrum disorder Tedesco, Robert Q4.L.D HandHold Adaptive, LLC
Hattie Larlham Autism Preschool Janini, Kathy Q4.Other Hattie Larlham Research Institute
Intranasal oxytocin for the treatment of children and adolescents with autism spectrum disorders (ASD) Anagnostou, Evdokia Q4.S.C Holland Bloorview Kids Rehabilitation Hospital
Parent-implemented social-pragmatic communication intervention for young children with developmental disabilities Angell, Maureen Q4.L.D Illinois State University
Mirtazapine treatment of anxiety in children and adolescents with pervasive developmental disorders McDougle, Christopher Q4.L.C Indiana University
Promoting early social-communicative competency in toddlers with autism Schertz, Hannah; Odom, Samuel; Baggett, Kathleen Q4.L.D Indiana University; University of North Carolina at Chapel Hill; University of Kansas
4/5-Randomized trial of parent training for young children with autism Swiezy, Naomi Q4.S.D Indiana University-Purdue University Indianapolis
Pharmacotherapy of pervasive developmental disorders Stigler, Kimberly Q4.L.C Indiana University-Purdue University Indianapolis
1/4-RUPP autism network: Guanfacine for the treatment of hyperactivity in PDD McDougle, Christopher Q4.L.C Indiana University-Purdue University Indianapolis
Targeted pharmacologic interventions for autism McDougle, Christopher Q4.L.C Indiana University-Purdue University Indianapolis
Enhancing inter-subjectivity in infants at high risk for autism Bryson, Susan; Brian, Jessica; Smith, Isabel; Zwaigenbaum, Lonnie; Roberts, Wendy Q4.S.F IWK Health Centre/Dalhousie University; University of Toronto; University of Alberta; The Hospital for Sick Children
The role of SHANK3 in the etiology of autism spectrum disorder Bangash, M. Ali Q4.S.B Johns Hopkins University
Dynamic regulation of Shank3 and ASD Worley, Paul Q4.S.B Johns Hopkins University
Investigation of the role of MET kinase in autism Dawson, Ted Q4.S.B Johns Hopkins University School of Medicine
Double masked placebo controlled trial of cholesterol in hypocholesterolemic ASD Tierney, Elaine Q4.S.C Kennedy Krieger Institute